WVU in the news: Are obesity drugs causing a severe complication? What the science says

The potent GLP-1 drugs are taken by millions of people worldwide to counter obesity, heart disease, diabetes and more. However, a rare and potentially fatal illness that might be linked to these blockbuster therapies is now causing alarm in some countries.

“Data about the risk of pancreatitis with GLP-1 use has been very heterogeneous,” says Ebubekir Daglilar, a gastroenterologist at West Virginia University in Charleston.